Medtronic Zukünftiges Wachstum
Future Kriterienprüfungen 1/6
Medtronic wird ein jährliches Gewinn- und Umsatzwachstum von 10.1% bzw. 4.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 10.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.2% betragen.
Wichtige Informationen
10.1%
Wachstumsrate der Gewinne
10.7%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 17.1% |
| Wachstumsrate der Einnahmen | 4.6% |
| Zukünftige Eigenkapitalrendite | 15.2% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 23 Nov 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Medtronic Q3 Earnings: A Solid Performance, But Bottom Line Still Needs Fixing
Nov 19Medtronic (NYSE:MDT) Hasn't Managed To Accelerate Its Returns
Nov 08
Medtronic: Undervalued But Trapped In Slow Growth (Rating Downgrade)
Oct 31Is It Time To Consider Buying Medtronic plc (NYSE:MDT)?
Oct 13Medtronic: Undervalued Dividend Aristocrat With High Margins
Oct 10An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 33% Undervalued
Sep 30Medtronic (NYSE:MDT) Boosts FY 2025 Guidance Amid Strong Q1 Earnings and Strategic Share Buybacks
Sep 16Medtronic: An Undervalued Stock With Durable Competitive Advantages
Sep 16Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Sep 05Medtronic: Is The Company Back?
Aug 26Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 4/30/2027 | 36,904 | 6,200 | 7,639 | 9,294 | 25 |
| 4/30/2026 | 35,126 | 5,733 | 6,857 | 8,710 | 32 |
| 4/30/2025 | 33,560 | 5,274 | 6,018 | 7,924 | 31 |
| 10/25/2024 | 32,996 | 4,288 | 5,499 | 7,195 | N/A |
| 7/26/2024 | 32,577 | 3,927 | 5,145 | 6,898 | N/A |
| 4/26/2024 | 32,364 | 3,676 | 5,200 | 6,787 | N/A |
| 1/26/2024 | 32,320 | 4,201 | 4,931 | 6,470 | N/A |
| 10/27/2023 | 31,958 | 4,102 | 4,045 | 5,570 | N/A |
| 7/28/2023 | 31,558 | 3,620 | 4,444 | 5,831 | N/A |
| 4/28/2023 | 31,227 | 3,758 | 4,580 | 6,039 | N/A |
| 1/27/2023 | 30,771 | 4,064 | 4,166 | 5,636 | N/A |
| 10/28/2022 | 30,806 | 4,321 | 4,822 | 6,290 | N/A |
| 7/29/2022 | 31,070 | 5,205 | 5,721 | 7,137 | N/A |
| 4/29/2022 | 31,686 | 5,039 | 5,978 | 7,346 | N/A |
| 1/28/2022 | 31,785 | 4,914 | 5,678 | 7,034 | N/A |
| 10/29/2021 | 31,798 | 4,704 | 5,773 | 7,162 | N/A |
| 7/30/2021 | 31,597 | 3,882 | 5,855 | 7,254 | N/A |
| 4/30/2021 | 30,117 | 3,606 | 4,885 | 6,240 | N/A |
| 1/29/2021 | 27,926 | 2,892 | 4,631 | 5,945 | N/A |
| 10/30/2020 | 27,868 | 3,537 | 4,752 | 5,996 | N/A |
| 7/31/2020 | 27,927 | 4,412 | 4,756 | 6,002 | N/A |
| 4/24/2020 | 28,913 | 4,789 | 6,021 | 7,234 | N/A |
| 1/24/2020 | 31,062 | 5,408 | 6,659 | 7,871 | N/A |
| 10/25/2019 | 30,891 | 4,762 | 6,298 | 7,519 | N/A |
| 7/26/2019 | 30,666 | 4,420 | 5,671 | 6,815 | N/A |
| 4/26/2019 | 30,557 | 4,631 | 5,873 | 7,007 | N/A |
| 1/25/2019 | 30,555 | 4,826 | 4,867 | 5,958 | N/A |
| 10/26/2018 | 30,378 | 2,168 | 4,864 | 5,905 | N/A |
| 7/27/2018 | 29,947 | 3,163 | N/A | 5,649 | N/A |
| 4/27/2018 | 29,953 | 3,104 | N/A | 4,684 | N/A |
| 1/26/2018 | 29,725 | 2,859 | N/A | 5,419 | N/A |
| 10/27/2017 | 29,639 | 5,069 | N/A | 5,502 | N/A |
| 7/28/2017 | 29,934 | 4,115 | N/A | 6,067 | N/A |
| 4/28/2017 | 29,710 | 4,028 | N/A | 6,880 | N/A |
| 1/27/2017 | 29,361 | 3,968 | N/A | 6,433 | N/A |
| 10/28/2016 | 29,012 | 4,242 | N/A | 6,145 | N/A |
| 7/29/2016 | 28,725 | 3,647 | N/A | 5,952 | N/A |
| 4/29/2016 | 28,833 | 3,538 | N/A | 5,218 | N/A |
| 1/29/2016 | 28,435 | 2,434 | N/A | 5,804 | N/A |
| 10/30/2015 | 25,819 | 2,316 | N/A | 5,774 | N/A |
| 7/31/2015 | 23,127 | 2,624 | N/A | 5,408 | N/A |
| 4/24/2015 | 20,261 | 2,675 | N/A | 4,902 | N/A |
| 1/23/2015 | 17,410 | 3,124 | N/A | 4,318 | N/A |
| 10/24/2014 | 17,255 | 2,909 | N/A | 4,163 | N/A |
| 7/25/2014 | 17,083 | 2,983 | N/A | 4,286 | N/A |
| 4/25/2014 | 16,893 | 3,065 | N/A | 4,959 | N/A |
| 1/24/2014 | 16,879 | 3,586 | N/A | 4,901 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: MDTDas prognostizierte Gewinnwachstum (10.1% pro Jahr) liegt über der Sparquote (2.6%).
Ertrag vs. Markt: MDTDie Erträge des Unternehmens (10.1% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (15.4% pro Jahr).
Hohe Wachstumserträge: MDTDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: MDTDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.9% pro Jahr).
Hohe Wachstumseinnahmen: MDTDie Einnahmen des Unternehmens (4.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: MDTDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.2%).